These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32198194)

  • 41. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J; Karpe F; Milne RW; Hamsten A
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triglyceride-rich lipoproteins and cardiovascular diseases.
    Xu D; Xie L; Cheng C; Xue F; Sun C
    Front Endocrinol (Lausanne); 2024; 15():1409653. PubMed ID: 38883601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoprotein lipase. Mechanism of formation of triglyceride-rich remnant particles from very low density lipoproteins and chylomicrons.
    Higgins JM; Fielding CJ
    Biochemistry; 1975 Jun; 14(11):2288-93. PubMed ID: 166652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
    Bjorkegren J; Packard CJ; Hamsten A; Bedford D; Caslake M; Foster L; Shepherd J; Stewart P; Karpe F
    J Lipid Res; 1996 Jan; 37(1):76-86. PubMed ID: 8820104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation of a procedure for exogenous isotopic labeling of lipoprotein triglyceride with radioactive triolein.
    Fielding CJ
    Biochim Biophys Acta; 1979 May; 573(2):255-65. PubMed ID: 221031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins.
    Saniabadi AR; Umemura K; Suzuki Y; Kondo K; Ikeda Y; Adachi M; Nakashima M
    Life Sci; 1998; 63(12):1065-74. PubMed ID: 9749829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells.
    Craig WY; Cooper AD
    J Lipid Res; 1988 Mar; 29(3):299-308. PubMed ID: 2837527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.
    Taskinen MR; Björnson E; Matikainen N; Söderlund S; Pietiläinen KH; Ainola M; Hakkarainen A; Lundbom N; Fuchs J; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
    Diabetes Obes Metab; 2021 May; 23(5):1191-1201. PubMed ID: 33502078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remnant lipoproteins as therapeutic targets.
    Havel RJ
    Curr Opin Lipidol; 2000 Dec; 11(6):615-20. PubMed ID: 11086335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.
    Shaik A; Rosenson RS
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):677-690. PubMed ID: 33710501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New and emerging regulators of intestinal lipoprotein secretion.
    Xiao C; Dash S; Morgantini C; Lewis GF
    Atherosclerosis; 2014 Apr; 233(2):608-615. PubMed ID: 24534456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism.
    Beisiegel U
    Curr Opin Lipidol; 1995 Jun; 6(3):117-22. PubMed ID: 7647999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins.
    Cohn JS; Marcoux C; Davignon J
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2474-86. PubMed ID: 10521378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins.
    Nakajima K; Tokita Y; Tanaka A; Takahashi S
    Clin Chim Acta; 2019 Aug; 495():382-393. PubMed ID: 31078566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk.
    Su JW; Nzekwu MM; Cabezas MC; Redgrave T; Proctor SD
    Eur J Clin Invest; 2009 Sep; 39(9):741-54. PubMed ID: 19563468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
    J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Atherogenic lipoprotein remnants in humans].
    Wikinski R; Schreier LE; Berg GA; Brites FD; López G; González AI; Zago V
    Medicina (B Aires); 2010; 70(4):375-80. PubMed ID: 20679062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.